Spuls PI - Search Results

1

The burden of psoriasis is not determined by disease severity only.

Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. Heydendael VM, et al. Among authors: spuls pi. J Investig Dermatol Symp Proc. 2004 Mar;9(2):131-5. doi: 10.1111/j.1087-0024.2004.09115.x. J Investig Dermatol Symp Proc. 2004. PMID: 15083779 Free article. Clinical Trial.

2

A systematic review of five systemic treatments for severe psoriasis.

Spuls PI, Witkamp L, Bossuyt PM, Bos JD. Spuls PI, et al. Br J Dermatol. 1997 Dec;137(6):943-9. Br J Dermatol. 1997. PMID: 9470912

3

Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis.

Van Leent EJ, Gräber M, Thurston M, Wagenaar A, Spuls PI, Bos JD. Van Leent EJ, et al. Among authors: spuls pi. Arch Dermatol. 1998 Jul;134(7):805-9. doi: 10.1001/archderm.134.7.805. Arch Dermatol. 1998. PMID: 9681343 Clinical Trial.

4

Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature.

Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Njoo MD, et al. Among authors: spuls pi. Arch Dermatol. 1998 Dec;134(12):1532-40. doi: 10.1001/archderm.134.12.1532. Arch Dermatol. 1998. PMID: 9875190

5

The development of practice guidelines for the treatment of severe plaque form psoriasis.

Spuls PI, Bossuyt PM, van Everdingen JJ, Witkamp L, Bos JD. Spuls PI, et al. Arch Dermatol. 1998 Dec;134(12):1591-6. doi: 10.1001/archderm.134.12.1591. Arch Dermatol. 1998. PMID: 9875199

6

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.

Van Leent EJ, Ebelin ME, Burtin P, Dorobek B, Spuls PI, Bos JD. Van Leent EJ, et al. Among authors: spuls pi. Dermatology. 2002;204(1):63-8. doi: 10.1159/000051813. Dermatology. 2002. PMID: 11834853 Clinical Trial.

7

Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels.

Heydendael VM, Spuls PI, Ten Berge IJ, Opmeer BC, Bos JD, de Rie MA. Heydendael VM, et al. Among authors: spuls pi. Br J Dermatol. 2002 Jul;147(1):122-9. doi: 10.1046/j.1365-2133.2002.04836.x. Br J Dermatol. 2002. PMID: 12100194 Review.

8

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.

Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, Bossuyt PM, Bos JD, de Rie MA. Heydendael VM, et al. Among authors: spuls pi. N Engl J Med. 2003 Aug 14;349(7):658-65. doi: 10.1056/NEJMoa021359. N Engl J Med. 2003. PMID: 12917302 Free article. Clinical Trial.

9

The course of chronic plaque-type psoriasis in placebo groups of randomized controlled studies.

Spuls PI, Witkamp L, Bossuyt PM, Bos JD. Spuls PI, et al. Arch Dermatol. 2004 Mar;140(3):338-44; discussion 344. doi: 10.1001/archderm.140.3.338. Arch Dermatol. 2004. PMID: 15023777 Review.

10

Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.

Opmeer BC, Heydendael VM, De Borgie CA, Spuls PI, Bossuyt PM, Bos JD, De Rie MA. Opmeer BC, et al. Among authors: spuls pi. Arch Dermatol. 2004 Jun;140(6):685-90. doi: 10.1001/archderm.140.6.685. Arch Dermatol. 2004. PMID: 15210458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page